ITPR1 and urinary bladder carcinoma: Moreover, changes in IP3R1 have been implicated in the biological properties of the tumors: for example, cisplatin-induced downregulation of IP3R1 expression was found to be associated with the acquisition of cisplatin resistance in bladder cancer cell lines (Tsunoda et al. 2005).